Capital Research Global Investors Insulet Corp Transaction History
Capital Research Global Investors
- $479 Billion
- Q2 2025
A detailed history of Capital Research Global Investors transactions in Insulet Corp stock. As of the latest transaction made, Capital Research Global Investors holds 4,736,127 shares of PODD stock, worth $1.47 Billion. This represents 0.31% of its overall portfolio holdings.
Number of Shares
4,736,127
Previous 6,076,540
22.06%
Holding current value
$1.47 Billion
Previous $1.6 Billion
6.75%
% of portfolio
0.31%
Previous 0.36%
Shares
32 transactions
Others Institutions Holding PODD
# of Institutions
884Shares Held
62.7MCall Options Held
313KPut Options Held
621K-
Vanguard Group Inc Valley Forge, PA8.71MShares$2.7 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.88 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.06MShares$946 Million0.04% of portfolio
-
Baillie Gifford & CO2.14MShares$661 Million0.53% of portfolio
-
Geode Capital Management, LLC Boston, MA1.93MShares$597 Million0.04% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $21.5B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...